BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2989014)

  • 1. Specific cell-mediated immunity in patients with epidermodysplasia verruciformis and plane warts.
    Haftek M; Jabłonska S; Orth G
    Dermatologica; 1985; 170(5):213-20. PubMed ID: 2989014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunofluorescence complement-fixation test for detection of human papilloma viruses in various warts and wartlike lesions of epidermodysplasia verruciformis.
    Chorzelski T; Jarzabek-Chorzelska M; Jabłońska S; Orth G; Rzesa G
    Arch Dermatol Res; 1983; 275(1):53-7. PubMed ID: 6303226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological aspects of wart regression with special reference to regression phenomenon of numerous flat warts. An experiment on tumor immunity in man by nature.
    Tagami H; Oguchi M; Ofuji S
    J Dermatol; 1983 Feb; 10(1):1-12. PubMed ID: 6306083
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunology of human warts.
    Briggaman RA; Wheeler CE
    J Am Acad Dermatol; 1979 Oct; 1(4):297-304. PubMed ID: 229134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vivo study of cell-mediated immunity in human warts. Preliminary results.
    Thivolet J; Hegazy MR; Viac J; Chardonnet Y
    Acta Derm Venereol; 1977; 57(4):317-9. PubMed ID: 70923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cell-mediated immunity in spontaneous regression of plane warts.
    Rogozinski TT; Jablonska S; Jarzabek-Chorzelska M
    Int J Dermatol; 1988 Jun; 27(5):322-6. PubMed ID: 2839432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of proteins of human papilloma viruses (HPV) and antibody response to HPV 1.
    Pfister H; zur Hausen H
    Med Microbiol Immunol; 1978 Nov; 166(1-4):13-9. PubMed ID: 214677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus?
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Rzesa G; Obałek S; Glinski W; Favre M; Croissant O
    J Invest Dermatol; 1979 Mar; 72(3):114-9. PubMed ID: 217936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological studies in epidermodysplasia verruciformis.
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Rzesa G; Obalek S; Glinski W; Favre M; Croissant O
    Bull Cancer; 1978; 65(2):183-90. PubMed ID: 212145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis.
    Orth G; Jablonska S; Favre M; Croissant O; Jarzabek-Chorzelska M; Rzesa G
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1537-41. PubMed ID: 206906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reactions in epidermodysplasia verruciformis.
    Pyrhönen S; Jablonska S; Obałek S; Kuismanen E
    Br J Dermatol; 1980 Mar; 102(3):247-54. PubMed ID: 6245674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immune responses in patients with warts.
    Morison WL
    Br J Dermatol; 1975 Nov; 93(5):553-6. PubMed ID: 1203179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity (CMI) to human wart virus and wart-associated tissue antigens.
    Lee AK; Eisinger M
    Clin Exp Immunol; 1976 Dec; 26(3):419-24. PubMed ID: 188577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis.
    Majewski S; Malejczyk J; Jablonska S; Misiewicz J; Rudnicka L; Obalek S; Orth G
    J Am Acad Dermatol; 1990 Mar; 22(3):423-7. PubMed ID: 2155952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific immunity to human papilloma virus (HPV) in patients with genital warts.
    Viac J; Staquet MJ; Miguet M; Chabanon M; Thivolet J
    Br J Vener Dis; 1978 Jun; 54(3):172-5. PubMed ID: 207383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plane warts under spontaneous regression. Immunopathologic study on cellular constituents leading to the inflammatory reaction.
    Iwatsuki K; Tagami H; Takigawa M; Yamada M
    Arch Dermatol; 1986 Jun; 122(6):655-9. PubMed ID: 3013102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression phenomenon of numerous flat warts--an experiment on the nature of tumor immunity in man.
    Tagami H
    Int J Dermatol; 1983 Dec; 22(10):570-1. PubMed ID: 6319307
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistent warts protected from immune attack by a blocking factor.
    Freed DL; Eyres KE
    Br J Dermatol; 1979 Jun; 100(6):731-3. PubMed ID: 465319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Decaris on cellular immunity in patients with selected dermatoses caused by papillomaviruses].
    Olszewska Z; Dabkowski R; Maniecka-Bryła I
    Przegl Dermatol; 1987; 74(4-5):280-5. PubMed ID: 2835793
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated immunity to human papillomavirus.
    Chardonnet Y; Viac J; Staquet MJ; Thivolet J
    Clin Dermatol; 1985; 3(4):156-64. PubMed ID: 2850854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.